anipharmaceuticals.com - ANIP Company profit before taxes, interest and amortization
ANI Pharmaceuticals is betting on the production of scarce, complex generics and the launch of Cortrophin Gel. Personnel stability is ensured by strict compliance with FDA standards and attractive bonuses. The level of net operating income before depreciation confirms the effectiveness of the strategy, where the value is maintained at 244.98. In-house manufacturing plants in the US and work with rare brands guarantee the company high margins.
ANI Pharmaceuticals, Inc. (ANIP) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio ANI Pharmaceuticals|ANIP - Long-Term Debt to Capital|Short-Term Debt to Capital ANI Pharmaceuticals Inc|ANIP - Company Debts|Debt to Book Value Ratio ANI Pharmaceuticals|ANIP - Company Long-Term Debts|Short-Term Debt Volume ANI Pharmaceuticals|Intermediate Coverage Ratio anipharmaceuticals.com
- earnings and market ratios statistics:
ANIP - Company Net Income|Forward Earnings ANI Pharmaceuticals|ANIP - P/E Multiple|Future Price to Earnings Multiple anipharmaceuticals.com|ANIP - PEG Multiple|EV/EBITDA Multiple ANI Pharmaceuticals|ANIP - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year ANI Pharmaceuticals|ANIP - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months anipharmaceuticals.com|ANIP - Earnings growth in current year|Earnings growth forecast for next year ANI Pharmaceuticals
Analysis of all company metrics:ANI Pharmaceuticals Corp - ANIP
Stable income for ANI Pharmaceuticals (ANIP) from its niche generic portfolio forms the foundation for generating real cash flow. This metric measures operating efficiency excluding depreciation and taxes, allowing the projected EBITDA level on the GURU.Markets platform to distinguish fundamental business growth from temporary market fluctuations and confirm the issuer's long-term financial stability.
Who ANI Pharmaceuticals competes with
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos)|Operating profit EBITDA MannKind Corp MNKD|AMPH - Profit before payment of interest, taxes and amortization|PCRX (Pacira Corp) - Operating profit before amortization|SPRY: Operating profit EBITDA|TBPH - Operating income before deduction of amortization|Operating profit before deduction of amortization AQST|SCPH: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tectonic Therapeutic, Inc. (TECX)|TNXP: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA SXTC (China SXT Pharmaceuticals, Inc.)|Income before deduction of interest, taxes and amortization EPRX|BioHarvest Sciences Inc. - Operating profit EBITDA|EXOZ - Operating profit EBITDA|oramed.com (ORMP) - Profit before payment of interest, taxes and amortization|Entera Bio - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization MindWalk Holdings|Operating profit before deduction of amortization abvcpharma.com (ABVC)|Operating profit EBITDA CPIX|Operating profit EBITDA Quantum BioPharma Ltd. (QNTM)|Operating profit EBITDA FGEN (FibroGen Corp)|TELO - Operating profit before deduction of amortization|Rani Therapeutics Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Synergy CHC Corp|RLYB (rallybio.com) - Operating profit before deduction of amortization|Lexaria Bioscience Corp. (LEXX) - Operating profit EBITDA|Operating profit before deduction of amortization PULM|PTHL (Pheton) - Company profit before taxes, interest and amortization|Operating profit EBITDA APM|Operating income before deduction of amortization lyratherapeutics.com|Operating profit EBITDA IBO (Impact BioMedical)|TNFA - Operating profit before deduction of amortization|cbdMD Corp - Operating profit EBITDA|PRFX - Operating profit EBITDA|altamiratherapeutics.com (CYTO) - Profit before payment of interest, taxes and amortization|LIPO (lipella.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization OptiNose|Pieris Pharmaceuticals Inc (PIRS) - Operating income before deduction of amortization|Operating profit EBITDA PROC|Operating profit EBITDA Petros Pharma (PTPI)|Profit before payment of interest, taxes and amortization Qilian International QLI|SLRN: Operating profit before amortization|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
